Floatz logo

Meperidine

Choledocholithiasis

National University of MalaysiaSmall moleculePhase 4 / ApprovedActive
BBB
72/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
57/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Choledocholithiasis cohort.

Asset / SponsorPhaseRating
MIDAZOLAM
National University of Malaysia
Phase 4BBB
ETOMIDATE
Cheju Halla General Hospital
Phase 4BB
(±)-2-(O-CHLOROPHENYL)-2-(METHYLAMINO)CYCLOHEXANONE
National University of Malaysia
Phase 2B
Gentamycin
National University of Malaysia
Phase 2CCC
CEFOXITIN
Yonsei University
N/AD

Same molecule, other indications

Meperidine is also rated in:

Major Depression DisordersDormant
BB
Indicative ·
68 / 100
View asset →
pancreatitisDormant
BB
Indicative ·
68 / 100
View asset →
hepatitisDormant
BB
Indicative ·
68 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →